The Drugs Controller General of India (DCGI) on Friday gave its permission to Bharat Biotech for conducting trials of intranasal booster doses against the coronavirus disease (Covid-19).
According to an input from news agency ANI, the trials will be held at nice different sites.
India will start administering the precautionary third doses of Covid vaccines from Jan 10. It will be given to health workers, frontline workers & senior citizens with co-morbidities. The decision to administer this 3rd dose was taken in view of the recent global surge of Covid cases. It was announced by PM Modi last month amid demands of boosters in…
A day ago, the Hyderabad-based pharmaceutical company’s anti-Covid vaccine Covaxin was recently granted regular market approval for use in the adult population subject to certain conditions. A similar nod has also been given to Serum Institute of India’s Covishield. Both the widely used vaccines in the country’s fight against the pandemic had so far been grante restricted use in emergency situations.
You may also like
-
Ayurveda and Diabetes Prevention: Lifestyle Lessons from Classical Principles
-
India Examines Regulatory Reforms to Allow Global Pharmaceutical Companies to Conduct First-in-Human Clinical Trials
-
CSIR-CCMB Scientists Identify New Potential Drug Targets Against Tuberculosis Bacterium
-
Ayurveda for Healthy Metabolism: Balancing Agni, Nutrition and Daily Living
-
India Records 38% Decline in TB Mortality, Achieves 94% Treatment Success Rate
